Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »


  • AC

    Alumni Connection

  • The Nine-Year Itch

    Sure, spam is a scourge. It’s too bad a Virginia jury’s tough sentence for a convicted spammer won’t make a difference.

  • Study: Genentech's Cancer Fighter Avastin Helps Sickest Patients

    A new study found cancer patients treated with a new drug survived two months longer than those treated only with chemotherapy. With FDA approval and more detailed research coming out, Avastin could become the next hot cancer-fighting medicine.

  • Seeing Heart Disease More Clearly

    A biotech startup is teaming with big pharma to develop substances that can spot heart attacks in the makingand find nearly invisible tumors.

    1 comment

  • Tech Test-MSN TV

    Microsoft’s foray into television slowed, but it hasn’t disappeared. With the Media Center and MSN TV, the gap between TVs and PCs has nearly closed.

  • Vaccine Truth or Dare

    A new vaccine in the works could prevent cervical cancer. But will it ever reach those who would benefit most?


From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me